Back | Next |
home / stock / cnsp / cnsp message board
Subject | By | Source | When |
---|---|---|---|
The now up | StockLogistics | investorshub | 04/25/2023 8:21:11 AM |
great article | PennyPusher786 | investorshub | 04/25/2023 4:03:11 AM |
The gaining last up | Awl416 | investorshub | 04/25/2023 2:01:00 AM |
$CNSP What do you make of this? | TheFinalCD | investorshub | 04/24/2023 6:26:44 PM |
Price now last up | StockLogistics | investorshub | 04/22/2023 9:11:43 AM |
The trading last trade up | StockLogistics | investorshub | 04/22/2023 12:16:59 AM |
NetworkNewsWire: NetworkNewsBreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Potentially Pi | NetworkNewsWire | investorshangout | 04/21/2023 9:08:01 PM |
NetworkNewsWire: Mechanical Nanosurgery Could Revolutionize Brain Cancer Treatment Glioblastoma is a | NetworkNewsWire | investorshangout | 04/21/2023 6:41:21 AM |
$CNSP The gaining | Pt3 | investorshub | 04/21/2023 5:17:11 AM |
Getting shorted like mofo... lol | PennyPusher786 | investorshub | 04/20/2023 2:42:08 PM |
Covers starting to roll in. Looking for that | Jess070283 | investorshub | 04/20/2023 2:28:46 PM |
It's not trading as if it's short sale | PennyPusher786 | investorshub | 04/20/2023 2:28:41 PM |
Looks like it's gonna break $3 hard when | PennyPusher786 | investorshub | 04/20/2023 2:24:43 PM |
Back in. This puppy is looking to bounce. | Jess070283 | investorshub | 04/20/2023 12:57:06 PM |
I have the same question! Serious reply...does that | Sun Dance Kid | investorshub | 04/20/2023 3:39:10 AM |
$CNSP best news of the day | PennyPusher786 | investorshub | 04/18/2023 8:55:57 PM |
How could $CNSP trade 41 & 48 | maverick_1 | investorshub | 04/18/2023 2:15:30 PM |
Out with 600% win for me!! Next!! | 81vette | investorshub | 04/17/2023 2:26:16 PM |
This can easily become a Halt-dippdr | PennyPusher786 | investorshub | 04/17/2023 2:03:04 PM |
What you think now? PM runner based on | PennyPusher786 | investorshub | 04/17/2023 1:50:04 PM |
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025 Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure HOUSTON, TX / ACC...
Scientists from the University of Florida in America have designed a new vaccine for cancer that prompts the immune system to target glioblastoma. Glioblastoma is an aggressive type of cancer that forms in the spinal cord and/or brain. Roughly 19,000 people in the European Union are afflicted...